Ambion Overview

  • Founded
  • 1989
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 300
Employees
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 3

Ambion General Information

Description

Developer of RNA-based reagents for life science research. The company offers molecular biology products, enzymes, drug development, life science research and other RNA-based products.

Contact Information

Website
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 2130 Woodward Street
  • Austin, TX 78744
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ambion Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Ambion‘s full profile, request access.

Request a free trial

Ambion Executive Team (1)

Name Title Board Seat Contact Info
Matthew Winkler Ph.D Founder & Chief Executive Officer
To view Ambion’s complete executive team members history, request access »

Ambion Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ambion Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Ambion‘s full profile, request access.

Request a free trial